Bogdi Supplier

How Will Kratom Make You Feel?

LaniBogdi — Thu, 28 Sep 2023 18:41:00 +0000

Thursday, 28/09/2023

Tikawidya

How Will Kratom Make You Feel?

Kratom Powder & Capsule

Low-dose kratom use has effects comparable to those of a moderate stimulant. But, how will Kratom make you feel?

Low-dose kratom use has effects comparable to those of a moderate stimulant. After taking this herbal supplement, many people feel a surge of energy, concentration, mental clarity, and a heightened feeling of sociability. In terms of energy, it’s comparable to the buzz you get from coffee. Increasing the dosage may have additional sedative effects. A user’s mood and energy levels may seem moderately flat after only one usage.

Mitragynine as well as 7-hydroxymitragynine are the primary active alkaloids involved for the bulk of the physiologic alterations that occur after intake.

The anti-inflammatory and immune-boosting properties of kratom were investigated in a 2017 research. Kratom users often report feeling relief from chronic pain and discomfort. It’s normal for individuals to turn to opioids and other pain relievers available without a doctor’s prescription.

Thus, kratom may provide a more organic approach to coping with or controlling the inflammation and pain. While more rigorous research is needed to assist put kratom on the market at large, anecdotal evidence is mounting.

Injections of HCG have helped many patients with fibromyalgia and other chronic pain conditions. There is some evidence that kratom may relieve pain in a similar way.

Nano Machine Result

Hi, There. Thank you for being here. My name is Lani harfisani, I am the owner of BogdiSupplier. It is such an honor for me to welcome you here.

Recent Post

The post How Will Kratom Make You Feel? appeared first on Bogdi Supplier.

3 Health Benefits of Kratom

LaniBogdi — Mon, 05 Sep 2022 18:28:00 +0000

Monday, 09/05/2022

Tikawidya

3 Health Benefits of Kratom

Get to know multiple possible health advantages of kratom! What are the 3 health benefits of Kratom?

Multiple possible health advantages of kratom have been uncovered via scientific investigation:

Stimulating Your Libido

Researchers are looking at whether or not Kratom might work as a sexual enhancement aid. The aphrodisiac properties of kratom were the subject of a systematic review and report by researchers. It was determined that kratom is an efficient plant-based sexual enhancer.

Soothing Effects

There are three varieties of Kratom, and they all work well to alleviate persistent pain. All three types, white vein, green vein, as well as red vein, block pain by binding to opioid receptors. 7-hydroxymitragynine, a component of kratom, is 13 times more powerful than morphine.

Although kratom, like codeine and morphine binds to opioid receptors, it is classified as an atypical opioid because of this. The selective inactivation of some signals by kratom may account for its comparatively milder side effects when compared to traditional opioids.

Mood-Boosting

The mood-boosting benefits of kratom are many. There is evidence that kratom may help those who are addicted to opioids. Evidence suggests it may reduce the discomfort associated with kicking morphine or alcohol.

It has been shown in other research that kratom may be useful as an antidepressant as well as a hunger suppressor. Kratom has been shown to reduce corticosterone levels in mice, according to one study. High levels of the stress hormone corticosterone are linked to emotional instability.

Kratom supplementation reduced food intake in another rat research by blocking activity in the hypothalamus, the region of the brain that controls hunger and food desires. More studies are required to determine whether kratom has the same effects in people.

Nano Machine Result

Hi, There. Thank you for being here. My name is Lani harfisani, I am the owner of BogdiSupplier. It is such an honor for me to welcome you here.

Recent Post

The post 3 Health Benefits of Kratom appeared first on Bogdi Supplier.

The AKA is working hard to ensure a safe and reliable supply of kratom from Indonesia

LaniBogdi — Mon, 22 Aug 2022 07:16:09 +0000

Monday, 08/22/2022

Zack Ruskin

The AKA is working hard to ensure a safe and reliable supply of kratom from Indonesia

AKA Delegtion

The American Kratom Association delegation recently traveled to Indonesia and was honored to meet with chief of the Presidential Staff, Moeldoko in Jakarta to discuss the importance of maintaining a supply of pure, unadulterated kratom raw materials from Indonesia to the United States. Mr. Moeldoko agreed that kratom is a significant export commodity that supports more than 200,000 farmers in some of the most impoverished areas of Indonesia, and he committed to aligning Indonesia’s policies on kratom with the new and emerging science showing its safety profile.

The AKA will continue to work with the Indonesian government and the U.S. FDA to resolve all issues related to kratom exported from Indonesia to meet FDA standards for purity and quality.

Source from AKA

Nano Machine Result

Hi, There. Thank you for being here. My name is Lani harfisani, I am the owner of BogdiSupplier. It is such an honor for me to welcome you here.

Recent Post

The post The AKA is working hard to ensure a safe and reliable supply of kratom from Indonesia appeared first on Bogdi Supplier.

How the American Kratom Association is Helping Kratom Fend Off the FDA

LaniBogdi — Wed, 04 Aug 2021 22:08:53 +0000

Thursday, 08/05/2021

Zack Ruskin

How the American Kratom Association is Helping Kratom Fend Off the FDA

AKA

When it comes to misinformation, we rarely consider our own federal agencies as culprits. However, in the case of kratom, the U.S. Food and Drug Administration (FDA) has waged what amounts to an all-out war in efforts to keep the plant (or, more specifically, its leaves) out of the hands of some 11 to 16 million consumers across the country.

On Tuesday, Bloom & Oil spoke with Top Tree Herbs co-founder Sam Weber about some of the ways in which kratom – a tree native to Southeast Asia with a diverse array of reported benefits – continues to be misunderstood in the eye of the mainstream.

While Weber’s primary focus is on offering kratom in the form of pre-packaged tea bags, Mac Haddow of the American Kratom Association (AKA) has been on the frontlines of a battle to prevent the U.S. Drug Enforcement Agency (DEA) and FDA from banning the substance for reasons devoid of fact and merit.

As the AKA’s Senior Fellow on Public Policy, Haddow has stayed busy, first in thwarting efforts to see kratom be scheduled under the Controlled Substances Act, and later on a state-by-state basis. As the fight continues, Haddow reveals how the misinformation at the heart of these agencies’ efforts has subsequently spread to our larger understanding – or, in many cases, fear – of kratom.

How did you become the AKA’s Senior Fellow on Public Policy?

I was actually hired by the American Kratom Association to help with the fight to resist the DEA’s scheduling of mitragynine and 7-hydroxymitragynine, which they published in the Federal Register on August 31st, 2016. That notice was done under what’s called the ‘Emergency Power’ section of the Controlled Substances Act, which means that within 30 days, it automatically kicks in. There’s no public comment period and there’s no judicial review on it. That section was designed for street drugs that pop up where the DEA simply cannot effectively go after them under the normal scheduling procedure, which takes a lot more time. The idea that the FDA, in their application for this, could list kratom as the equivalent of a drug that was killing people on the street, and label it an emergency was absurd on its face because what they listed, at the time, were 33 deaths that had occurred worldwide.

Not even in the United States — worldwide — and that was over a six-year period. It wasn’t like it just popped up and they had to swat it down. This was clearly an abuse of the authority that was granted to the DEA, and, in this case, the FDA, for recommending it for that section of the Controlled Substances Act. When I was hired, I told the AKA that they didn’t have much of a chance because there was no precedent. The DEA had never withdrawn a scheduling notice using this section of the law before. In fact, all 82 previous scheduling efforts had been successful. The only opportunity that I saw — as well as the others who joined in the effort — was to establish a record that would show the abuse of the authority of the FDA and the DEA in taking this action. What we didn’t fully contemplate was the outrage of the kratom-consuming public, which at that time was estimated to be between three and five million people.

And what role did they play?

Thousands of people called or emailed the DEA, notwithstanding the fact there was no formal comment period. Nonetheless, we reached out and solicited signatures. On a letter from U.S. Congressmembers of the House, we got 51 members to sign: 26 Republicans and 25 Democrats. We also got 13 members of the Senate.

In terms of a diversity in philosophies and political leanings, you had Bernie Sanders on one hand, who is clearly one of the most liberal members of the Senate. At the time, Senator Orrin Hatch, who has since retired, was one of the most conservative but both senators shared this belief that the decision made by the DEA was incorrect. That led to the unprecedented withdrawal of the scheduling notice on October 13, 2016. First time it ever happened.

Then the DEA told the FDA to do an expedited review of the 8 factor analysis. The ‘Emergency Power’ section allows for three factors to be considered, all related to safety. The 8 factors is a far more comprehensive look at the actual structure of the substance, including its safety profile and an assessment of its addiction liability. The DEA asked the FDA to have that done by December 1, 2016. In the interim, they opened a public comment period to allow for individual kratom consumers to make comments.

I’d imagine a lot of folks made comments?

During that interim space, between October 13 and December 1, there were 23,232 comments that were submitted officially for the record, 99.1% of which were opposing the scheduling of kratom.

They were really across-the-board too: you had veterans, law enforcement officials, medical professionals, and the average consumer all saying this was a mistake and shouldn’t be done. We’d also been contacted by a former NIDA researcher who had done dozens of these 8 factor analyses and understood exactly what the criteria was. He volunteered to help on a pro bono basis. His name is Dr. Jack Henningfield.

On the day before it was due, he submitted an 8 factor analysis, which is what the FDA was obligated to provide in justification for it. The FDA failed to meet the deadline, so we went into a limbo period. Up until that time, my experience had been working in the dietary supplement industry and the natural substance industry. I had worked for Senator Orrin Hatch, who was the champion of dietary supplement, vitamin, and natural product, consumers. Then I worked for a while at the Department of Health and Human Services (HHS) where the FDA is, of course, a party of that agency and that department, and I got a firsthand look at the way that the FDA operates — particularly with its bias against any product that they don’t like that does not go through the new drug application process.

I actually saw what literally is a deja vu moment where what the FDA tried to do in 2016 with kratom — and have continued since then to try to do — is equivalent to what the FDA attempted to do in the early 90s when they demonized all dietary supplements and all vitamins by claiming that they were killing people and that they were dangerously adulterated.

They said these products had all of these terrible interactions with existing prescription medications and that all of them had to be banned from the marketplace and put through the new drug application process. At that time, emails weren’t available — this was the early 90s — so hundreds of thousands of consumers sent letters and made phone calls. In fact, the volume of calls about what was called the Dietary Supplement Health and Education Act (DSHEA) was so high that it famously shut down the US Capitol switchboard.

What that bill did was it significantly limited the authority of the FDA to try to keep dietary supplements off the market. It made an important step to require the safety profile to be submitted in what’s called a ‘new dietary ingredient notification,’ so the manufacturers have to prove that it’s a safe product. That helped to eliminate the adulterated products, which were in fact, as the FDA correctly pointed out, killing people. That’s true with kratom, so we obviously need the same kind of regulatory scheme that would restrict the FDA’s ability to overreach and restrict their regulatory aggressiveness in this area going forward.

After that was pulled, what happened next?

At some point, the American Kratom Association had to pivot from playing defense, because the FDA is very aggressive in their disinformation campaign. They did finally submit an 8 factor analysis on October 17th, 2017 — almost a year after it was due — and then they started to demonize kratom by calling it an opioid, which isn’t true. They called it an ‘opioid analogue,’ which is untrue.

They claimed that their phase modeling system — which is a trumped-up computer system, like they wouldn’t accept a new drug application that was evaluated by that system — but they wanted to make a major policy change, like scheduling kratom, based on predictive modeling that was all based on their claim that the binding affinity of the mitragynine and 7-hydroxymitragynine to new opioid receptors in the brain was so significant that it mimicked and actually mirrored the activity of opioids.

That is pharmacologically incorrect but they had to make that claim in order to get meet the criteria for the Controlled Substances Act. They literally lied about the criteria and the basis for it in order to squeeze and shoehorn themselves into that position, which I think was to their detriment. What happened was the National Institute on Drug Abuse (NIDA) and the FDA collaborated together and formulated a recommendation, which they then submitted to HHS.

HHS is supposed to do an independent evaluation. Then, if they concur, they send it to the DEA and the Department of Defense (DoD). That’s what happened in 2017. The FDA consistently refused to meet with the AKA but we did secure a meeting with the Assistant Secretary for Health, who was the delegated agent at HHS to make these recommendations. We made a presentation and we believed that they’d accepted the information we provided. They had asked for supplemental information, which we gave them, and then we didn’t hear a word.

What we didn’t know is that on August 16, 2018, the HHS had formally rescinded the scheduling recommendation. The reasoning that they provided was, in essence, that the FDA had not proven its case and that emerging science undermined the claims about the addiction liability of kratom. They were referencing two NIDA-funded studies that showed there was no addiction liability to kratom and that legitimate scientists disagree about the role that kratom played in these deaths.

That, of course, has now been proven to be absurd for them to claim that there are cases of death from kratom.

Can you elaborate on that?

Absolutely. In fact, what they show is polydrug use, which NIDA has confirmed, and underlying medical conditions and some adulterated kratom products. That’s what’s causing these deaths, all of which are not the standard that the Controlled Substances Act requires. That and then the letter made what we think were the most powerful point, which is that by banning kratom, you would put millions of kratom consumers at risk of significant harm, including death, because you would force them off of kratom and onto more dangerous opioids that have a much larger safety profile than kratom ever could.

By doing that, you will actually cause more people to die. If you believe anything about our healthcare system, it should be that we believe in harm reduction and that our policies to reflect that. Well, in this particular case, the FDA got caught flat-footed with their hand in the cookie jar. They were wrong.

The interesting thing is that we didn’t know that decision had actually been made. It was only because of the oversight efforts of Congressman Mark Pocan from Wisconsin and Congressman Morgan Griffith from Virginia, who asked for and received the letter that had been transmitted. The explanation for why the letter had not been made public was that the FDA insisted on invoking what’s called a ‘regulatory review provision’ that exempted them from the FOIA (Freedom of Information Act). It took members of Congress asking for this letter, and when they received it, it exposed the big lie that the FDA has been telling about kratom for a long time.

What exactly does that ‘Big Lie’ consist of with regards to kratom?

There were two things in the letter that were especially astounding.

First, the day after the FDA knew that the HHS had formally and officially rescinded the scheduling recommendation, Scott Gottlieb, then Commissioner of the FDA, went on a Twitter tirade about the dangers of kratom and continued to prosecute that case in webinars and any other form the FDA could find to talk to state agencies and law enforcement, with public health officials, with medical examiners and coroners, all to encourage them to blame kratom for these deaths, even though that couldn’t be supported from a scientific basis.

All of that was happening after they knew that the HHS had formally rescinded the recommendation on the basis that the FDA didn’t prove their case but they continued to tell the big lie to the American people.

When they were caught, when the letter was released, the FDA’s excuse was that they have no duty or obligation whatsoever to share news of the rescission and yet they publicly announced when it was submitted to the FDA and the DEA and made a big deal about it. For them to say that they don’t have any duty or responsibility flies in the face of what we believe about a credible and trustworthy agency that is tasked with protecting the public health. When the Assistant Secretary for Health says that by scheduling kratom, you’re putting millions of Americans at high risk of being forced onto more dangerous substances?

If there’s a more compelling case to show that the FDA has lost the trust of the American people, I don’t know what it is. They simply booted this badly and they should have accepted responsibility for the bad actions that they took.

Tell me more about pivoting from defense to offense when it comes to kratom consumer protections.

In 2016, when they lost that battle, the FDA then went out encouraged states to ban kratom. They convinced six states to do it between 2012 and 2016 but from 2016 onwards, there were 18 states that proposed bans on kratom and we’ve won in every one of those states.

We showed the science and we explained to lawmakers that public policy is best served by allowing for kratom to remain on the market, so the FDA sharpened their attacks. They made it clear that there are adulterated products out there and that said kratom products are killing people, so we went on the offense by encouraging states to pass the Kratom Consumer Protection Act (KCPA).

What that state law does is what the FDA should be doing right now: it bans the sale of any kratom product that is adulterated with a dangerous substance, be it fentanyl, morphine, heroin, buprenorphine, etc. There’s any number of substances that these bad actors are adding to kratom to give it a kick that the natural product does not have. They want to encourage sales and increase sales.

What’s the solution presented by the Kratom Consumer Protection Act?

To ban all of those dangerous substances. We saw four states that passed it in 2019: Utah, Georgia, Arizona, and Nevada. In 2020, we were well on our way to doubling that number, or more, and then Covid-19 hit. We’ve had great success in the state of Missouri. It passed 144-0 in the House and went to the Senate’s general laws committee and passed unanimously on a ‘do pass’ recommendation. It’s now waiting senate floor action.

In the state of Oklahoma, it passed 96-1 in the House and 45-1 in the Senate. It’s now awaiting the governor’s signature. The Texas House of Representatives just passed it 118-9 and it’s now headed to the senate there. We’re seeing that kind of energy and inertia building across the country, in various states where these legislators are evaluating this.

We’re seeing action in Wisconsin, Rhode Island, and in Vermont — and those are banned states. We’ve got a meeting scheduled with the Secretary of Health in Arkansas, another banned state where they acted on the FDA’s misinformation campaign. We’re hoping that they’ll rescind it. We’re working hard to be on the offense to protect American consumers, which the FDA has an obligation to do but refused to honor because of their bias against natural products, particularly kratom.

For the states that did enact bans, will it now require a two-step approach to undo the ban and then put in the KCPA?

It’s a complex process, depending on the state.

In Wisconsin, the Senate Health Committee, last year, before COVID, had opened up what’s called a bill file. They did it unanimously, so bipartisan, and it would rescind the ban and replace it with the Kratom Consumer Protection Act. In the state of Rhode Island, another banned state, same thing. The state Health Director initially opened up a formal review of the ban, in the first place, and we were disappointed that they testified at the first hearing on the Kratom Consumer Protection Act saying that they wanted to maintain their position and just repeating all of the FDA’s misinformation. That was very disappointing to us.

In the state of Vermont, it’s going to require a two-step process: one to rescind the ban and one to replace it with the KCPA. The same will be true in Indiana. In the state of Alabama, we were unsuccessful in getting the bill filed this year only because they were already fighting a battle on medical marijuana and our chief sponsors simply decided to give it until the next session but we’ll be teed-up to do that in January.

Arkansas is another interesting situation. They also banned it because of the FDA. In fact, it was a single doctor who’s in the addiction recovery business who recommended to the state’s Department of Health, back in 2015, that kratom should be banned. The document they use repeated all of the FDA’s untrue statements about kratom. The Secretary of Health there has agreed to a meeting. The reason that’s important is that the Arkansas legislature only meets every other year and they just concluded their work this month, so this is going to be something where we have to fight on the administrative level, and then, hopefully, get the legislature to affirm it when they meet in two years.

Each state is a little different. They each require some tweaking of our legislation proposal. In some states, we’ve also seen this ridiculous opposition form, which is fully uninformed. Mississippi is a prime example of that.

There’s a very active anti-kratom group led by the Mississippi Medical Association and they’re doing the FDA’s bidding, so it’s been very difficult to win them over, even though in the last session, we had the Senate Drug Policy Committee unanimously replace a ban bill with the Kratom Consumer Protection Act. However, it had to be referred jointly to another Senate committee, the Judiciary Committee, and that chairman bowed to the wishes of the Mississippi Medical Association. Again, all owing to bad information the FDA has pushed.

But we’re doing great in the U.S. and we’re going to see more success in the next year or so. I think we’re going to overwhelm them, eventually, to the point where the FDA will finally have to do the right thing.

Would every state passing the KCPA be enough in the AKA’s eyes?

Ultimately, it’s going to take congressional action, just like they did for DSHEA. When we get to a critical mass of states that have passed the KCPA, I think that will create the inertia at the federal level for there to be a federal bill filed which corrects what the FDA is doing and properly regulates kratom so that we’re protecting consumers against contaminants and adulterants and making sure that it’s manufactured with Good Manufacturing Practices and that it’s not subject to salmonella and E. coli and heavy metals. Those are all risks that are present if you don’t have these kinds of regulations in place.

As best as you understand it, how many kratom users are there in the U.S.?

An interesting byproduct of the attack by the FDA, and their attempt to have kratom scheduled in 2016, was literally an explosion of use because it drew attention to a product that many people on social media platforms were reporting had saved their lives.

You have a consumer study that was done by Dr. Oliver Grundmann, out of the University of Florida, which looked at the adult kratom consumer population in America. What he determined was that about a third of kratom consumers use it like you would a cup of coffee in the morning: for an energy boost and increased focus. Another third uses it for benefits in smoothing out moods and reducing anxiety, while a third group uses kratom to manage acute and chronic pain as a replacement for opioids or other painkillers, either prescribed by physicians or that they otherwise got hooked on in order to manage their pain.

We don’t have any opposition to a doctor having those kinds of medicines in their toolbox to help people but when people find themselves trapped in a cycle of taking these chemically-manufactured substances and then replace it with kratom, we think that’s appropriate use, individually, as well. It’s not something that should be advertised or marketed by any kratom manufacturer as having a therapeutic benefit if it has not gone through the new drug application process. We understand that there are appropriate restrictions on what individual manufacturers can say in terms of its intended use, but an individual can put it to whatever use that they choose, and they’ve found it beneficial.

Looking at each one of these groups that represents a third of kratom users, I think that third group is expanding a little bit as people understand that this is a potential lifeline away from addiction and overdose, particularly during Covid-19, where we’re seeing a spike in overdose deaths.

The FDA has severely restricted our ability to collect valid data about the transactions that are done by kratom retailers in the United States, so we looked to Indonesia, where 95% of kratom raw materials that come into the United States originate from. I went over there and participated in a symposium, in 2019, where the kratom growers made a presentation about the volume increase in exports per month, and then per year, and the Minister of Agriculture provided their data.

What it essentially came down to is that you’ve created a marketplace where, today, just over 4600 metric tons of kratom is being imported into the United States from Indonesia every month. Well if you break down the metric tons into grams and then break that out by what the average consumer uses in a day, depending on the number of grams that are consumed on an average basis, we’ve determined that there are between 11 and 16 million kratom consumers, which is up from 3 to 5 million in 2016. Remember, the average consumed is important because some people may use kratom, say, two or three times a week while others are using it at higher dose levels, three or four times a week, or even every day at even higher dose levels.

Based on the volume of kratom raw materials that are being shipped to the United States every month, it’s a reasonable conclusion. We would like to have something more specific, that’s driven by actual sales data, once we’re successful in getting the import alert removed. I think that that will open the door for that kind of analysis.

That’s a huge number!

There was a report that was just issued, from a government-funded study, where the researcher determined that there were just over two million kratom consumers in the United States, but you have to look at the methodology. First off, they were only looking at people that are in that third category of kratom users, who are trying to manage acute and chronic pain as a replacement for other drugs. And, by the way, it’s a growing area because Johns Hopkins University did a study on adult kratom users in this space and they found that 87% of those kratom users reported that they had significant reduction in withdrawal symptoms from the opioids they were taking. And 35% reported they were opioid-free within a year. That’s dramatic.

That’s what’s fueled, I think, a lot of the growth in the kratom marketplace: people who are successfully using this as an alternative to highly addictive and potentially deadly opioid medications. In that context, it’s understandable that we would see this dramatic increase in the usage of kratom. But the FDA, of course, continues to demonize it.

Nano Machine Result

Hi, There. Thank you for being here. My name is Lani harfisani, I am the owner of BogdiSupplier. It is such an honor for me to welcome you here.

Recent Post

The post How the American Kratom Association is Helping Kratom Fend Off the FDA appeared first on Bogdi Supplier.

Kratom FDA Import Alert 54-15: No Need to Panic

LaniBogdi — Wed, 04 Aug 2021 20:23:24 +0000

Thursday, 08/05/2021

Chelsea Brotherton

Kratom FDA Import Alert 54-15: No Need to Panic

kratom delivery preparation

On April 8 the FDA reissued an import alert pertaining to Kratom. This alert is meant to guide workers in the field to detain products containing Kratom at the U.S. borders. However, don’t fret; the supply of Kratom in the U.S. is not in danger.

What is the Kratom FDA Import Alert?

The Import alert issued by the FDA is specifically called Import Alert 54-15. Simply, it lists several companies whose shipments are subject to detention without physical examination (DWPE) at U.S. borders. This order has been in effect as early as 2014, so why is this news now?

The published date of the import alert has been updated because of additions to the listed companies who have been so-called “red listed.” Basically, nothing about the actual wording of the import alert has changed. The only new thing present is the updated list of companies whose products are now subject to detention without physical examination.

Why is there a Kratom FDA Import Alert?

So why is Kratom even on an import alert list? Well, that has a lot to do with product labeling and FDA approval. Kratom is not approved by the FDA for sale as a nutritional or dietary supplement. So, the products from companies on the red list are there usually because of mislabeling. Kratom is legal for sale as a ‘food’ product, and confiscated Kratom products are not complying with this label.

This labeling issue is important, because it speaks to the still present need for more research on Kratom, and regulation of Kratom to ensure that customers are consuming safe, and quality products. The current concern is that Kratom “appears to be a dietary supplement or contains a dietary ingredient that is a new dietary ingredient for which there is inadequate information to provide reasonable assurance that such ingredient does not present a significant or unreasonable risk of illness or injury.” If the Kratom Consumer Protection Act could be passed country wide there would be an easy distinction between safe and legal Kratom, and adulterated products.

FDA Position on Kratom

The FDA’s stance on Kratom is a little confusing for anyone who knows all of the facts. While the FDA import alert on Kratom states that ” there does not appear to be a history of use or other evidence of safety establishing that kratom will reasonably be expected to be safe as a dietary ingredient. In fact, the scientific literature disclosed serious concerns regarding the toxicity of Kratom in multiple organ systems. Consumption of Kratom can lead to a number of health impacts”

However, this is confusing given the information the FDA withheld from the public that was finally published by the American Kratom Association. This revealed that the information used by the FDA to try and criminalize Kratom was rescinded because it was incorrect. The US Department of Health and Human Services sent a letter to the FDA detailing how Kratom does not meet requirements to be banned, Further, they highlight the “significant risk of immediate adverse public health consequences for potentially millions of users” if Kratom were to be banned. Read the full text of this letter here.

What the American Kratom Association Thinks

A representative from the American Kratom Association (AKA) said that the import alert is important, because of how Kratom is being imported into the US. The AKA does not support Kratom vendors who market their products as dietary or health supplements. This is exactly the type of products that the import alert is targeting. The AKA specifies, though, that the FDA does not have the authority to confiscate Kratom that is unadulterated and sold as food with no dietary or health claims.
The AKA has held a Kratom FDA import alert webinar to discuss the subject.

Conclusion

We’ve seen a little bit of panic from customers worried about their supply of Kratom. We urge you not to worry! Our supply of Kratom isn’t going anywhere. The general shipment of pure unadulterated Kratom into the US is not at risk. However, Kratom is still facing defamation from the FDA, and Kratom advocates will need to continue in their vigilance to keep safe and natural Kratom in the hands of customers that need it.

Nano Machine Result

Hi, There. Thank you for being here. My name is Lani harfisani, I am the owner of BogdiSupplier. It is such an honor for me to welcome you here.

Recent Post

The post Kratom FDA Import Alert 54-15: No Need to Panic appeared first on Bogdi Supplier.

Why the FDA Is Suppressing Kratom

LaniBogdi — Wed, 04 Aug 2021 19:12:57 +0000

Thursday, 08/05/2021

Paul Kemp

Why the FDA Is Suppressing Kratom

FDA

Kratom received a hard slap on the hand recently to remind us all that those who sell kratom must play by the FDA’s confusing rules.

A very careful reading of the press release announcing the raid, which took what the U.S. Food & Drug Administration said was $5 million dollars worth of kratom off the market, could leave the average person scratching their head.

My quick scan of their Web site, immediately after the bust, found no claims that kratom was to be used for medicinal purposes at all. The site has now been taken down “for maintenance” so it is impossible to tell what it said that purportedly caused the raid.

This much we know:

On September 25th, Federal Marshalls raided the Warehouse of Rosefield Management in Van Nuys, California. twenty-five-thousand pounds of the herb kratom were seized.

The crime? “A related company, Wholesale Shamanic Herbs, promoted kratom on its website with claims that the product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease.” Or so the FDA says.

The FDA filed a complaint in the U.S. District Court for the Central District of California alleging that kratom is an unapproved new drug and a misbranded drug under the Federal Food, Drug, and Cosmetic Act.

It would seem that — for the moment — a company can possess and sell this herb, but they can’t say anything about what it is used for.

Kratom is still technically legal, but the FDA is obviously not happy about that and is willing to mis-state one key fact to mislead the public to agree.

Kratom Has Not Paid for the Privilege of Being Sold and Marketed in the U.S.

The story of this unusual herb, which has been used for centuries in Southeast Asia as a treatment for those withdrawing from opium and heroin addiction, as well as many other conditions including diabetes, diarrhea, and cough, is a long and fascinating one.

It is, perhaps more accurate to say that this herb was confiscated because it is being used — very effectively — as a way for America’s prescription drug addicts to break free without experiencing the usually traumatic withdrawal symptoms that stop most victims of Oxycontin and other opioids from getting clean.

One would think this country would welcome a solution to the problem that is causing a dramatic rise in the annual number of overdose deaths, with a growing number among women. Unfortunately, the true crime seems to be promoting the cessation of addiction, without the medically approved creation of a new, more-tenacious addiction to another set of pharmaceutical drugs under the care of a medical doctor or professional drug rehab counselor.

The list of DEA complaints alleging dire consequences for those who use kratom is equally applicable to those who drink too much beer, wine, or whiskey — which also are regulated and we must assume are “safe and effective“.

Consumption of kratom — the DEA and FDA say — can lead to a number of health problems including respiratory depression, nervousness, agitation, aggression, sleeplessness, hallucinations, delusions, loss of libido, tremors, skin hyperpigmentation, nausea, vomiting, constipation and severe withdrawal signs and symptoms.

The accusation that kratom causes respiratory depression is completely in conflict with this scientific research that shows the promise of this non-opiate painkiller. All the opioid drugs currently prescribed, on the other hand, do cause this deadly risk.

Here is the quote from Wikipedia’s listing for 7-Hydroxymitragynine: “One notable distinction between 7-hydroxymitragynine and traditional opioids is that 7-hydroxymitragynine does not cause hypoventilation (respiratory depression) and therefore does not carry the primary safety risk associated with traditional opioids.”

As usual, the FDA’s accusations are comical, in addition to being inaccurate: nervousness, agitation, aggression, sleeplessness, hallucinations, delusions, loss of libido, tremors, skin hyperpigmentation, nausea, vomiting, constipation and severe withdrawal signs and symptoms.

Nervousness, agitation, aggression, sleeplessness, and tremors can equally be caused by numerous drugs the FDA has approved for use, including coffee. Why are these other FDA-approved products permitted?

Alcohol, also regulated by the FDA, has also been known to cause nausea, vomiting, hallucinations (Pink Elephants, anyone?), tremors, and severe withdrawal symptoms. Why is alcohol allowed to be openly sold and consumed at sporting events where children are present?

Withdrawal from heavy consumption of alcohol over an extended period of time can result in “alcohol withdrawal syndrome: increased hand tremor, insomnia, nausea or vomiting, transient hallucinations (auditory, visual or tactile), psychomotor agitation, anxiety, tonic-clonic seizures, and autonomic instability.(Thanks to Wikipedia).

Oddly enough nausea and vomiting are the only unpleasant results of kratom use that ring true — and these are only found in those who accidentally (or purposely) take more than a reasonable quantity of the herb.

Hyperpigmentation has only been a problem for those who have worked for years in the bright sun of the jungles of Southeast Asia, while chewing quantities of kratom leaves to support their hard labor cheerfully. I have never heard of any U.S. or European kratom-user complaining of hyperpigmentation, though — if true — kratom might also be marketed as a sunless tanning aid.

But seriously, what is this fuss about kratom all about?

This all boils down to a turf battle between the established monopoly the pharmaceutical industry has over the distribution of products and information about those products — and a brash new herb which has burst onto the U.S. market as a better solution to (among other things) the U.S. opioid addiction crisis.

Big Pharma bought their way into a monopoly stake in the U.S. system of medical care. The FDA is the officially-sanctioned watchdog over what we may take — and what we may be told — for our health issues.

The FDA is staffed and advised at the higher levels by many individuals with ties to the pharmaceutical industry. Can you say, “Conflict of Interest? I bet you can!”

Our safety — and truth in advertising — are not the primary concern of the FDA, as anyone with a vaccine-injured child can attest.

Occasionally, as we are seeing with medical marijuana, a product which is not approved by the FDA is left alone, apparently because there is so much tax revenue to be gained by doing so. (Oh…and also because the federal government holds a patent on one of the drugs made from cannabis.)

Kratom is a newcomer which — although it has a long history of proven success and safety in countries where it grows — has not come up with the billions of dollars required to pay for the privilege of being sold on the U.S. market.

Kratom Has Not Paid the Piper

If absolute safety were really the issue, we would not have items such as alcohol, tobacco, vaccines, aspartame, Oxycontin, Tylenol, Fosamax and GMO foods being sold on the U.S. market.

Because these products have paid the fee to cross the barrier to entry in the huge U.S. market — and they can easily afford the occasional billion dollar fines for the deaths and injuries they frequently cause — they are permitted to do business here.

A fledgeling, disorganized industry marketing a plant substance that has never, by itself, caused a reported death in centuries of use doesn’t stand a chance against a de facto drug monopoly whose turf is protected by the FDA. Or, does it?

If Our Medical System Is So Great, Why Is Our Health Hitting New Lows?

If the FDA is watching over the safety of the drugs we use, what are we to make of the 100,000-plus deaths each year from pharmaceutical drugs?

Is a “Black Box” warning on the package of pills sufficient to protect us from overdose (in the case of Oxycontin) or osteonecrosis of the jaw (in the case of Fosamax)? Paying the FDA a billion or two as a fine for deceptive marketing and letting them keep selling their deadly products doesn’t seem like much protection.

The only ones getting good protection from the FDA are Big Pharma. They have paid the fee and are permitted to market products that are addictive, deadly, and legal.

They are protected from competition by an herb with considerable medical research behind it — an herb, kratom, that is preferred by hundreds of thousands of U.S. opioid, heroin, and benzodiazepine drug addicts.

One would think the American people and their government, in particular, would be very happy to welcome many former drug addicts back into the realm of productive, taxpaying citizens. What is truly amazing is that these citizens pay for their own do-it-yourself detox process, because they can’t charge it off to insurance or Medicare/Medicaid.

What a bonus for the taxpayers! Hundreds of thousands of former prescription drug addicts are now free of their habit, having paid for their own self-treatment — all thanks to kratom.

Many no longer use kratom. Some others use it only occasionally when pain flares or anxiety raises its ugly head.

Most, like this writer, say quitting kratom is less arduous than quitting its sister herb, caffeine.

So, tell me again — What is the FDA protecting us from?

Or, perhaps it is more accurate to ask, “Whom is the FDA protecting? The American public or the special interests of the pharmaceutical industry and the redundant jobs of the rehab industry?”

Nano Machine Result

Hi, There. Thank you for being here. My name is Lani harfisani, I am the owner of BogdiSupplier. It is such an honor for me to welcome you here.

Recent Post

The post Why the FDA Is Suppressing Kratom appeared first on Bogdi Supplier.

Salmonella-Laced Kratom Worth $400K Seized By CBP In Detroit From China

LaniBogdi — Sun, 01 Aug 2021 21:44:46 +0000

Monday, 06/23/2021

Brooklyn K.

Salmonella-Laced Kratom Worth $400K Seized By CBP In Detroit From China

Every day, more and more people try kratom. A single dose of five grams of kratom is all you need to combat stress, pain, a bad mood for hours. While there are hundreds if not thousands of vendors in the United States, there are always risk involved in purchasing kratom online. One of the biggest risks is exposure to tainted kratom.

While you may believe otherwise, there are vendors who have little to no morals. They will sell tainted kratom without giving the buyer a second thought. For example, a Detroit kratom vendor was discovered with about 1,200 pounds of kratom powder that was estimated to be worth more than $400,000.

Salmonella Bacteria

A thorough inspection of the powdered kratom revealed it was tainted with salmonella, a bacteria responsible for more than 1.3 million cases of illness in the United States each year. The illness begins with stomach cramps which continue to worsen over time. The stomach cramps are followed by diarrhea and potentially fever, leading to the need for immediate medical treatment and even worse hospitalization.

The onset of salmonella symptoms is about six hours after exposure. In some cases, patients have reported being asymptomatic for up to six days after exposure. When the symptoms do finally appear, they are very powerful.

Originated From China

Kratom originates from Indonesia, Malaysia, Vietnam, and Southeast Asia. In this case, the salmonella-tainted kratom originated from China. Laboratory testing revealed the imported kratom was not botanical soils, as first thought by US Customs and Border Protection’s (CBP) Office of Field Operations.

The kratom was being stored at the Fort Street Cargo Facility in Detroit. A sample of the substance was tested by the US Food and Drug Administration (FDA). The results revealed the green powder was positively kratom. Further testing showed the kratom to be contaminated with the bacteria salmonella.

Nano Machine Result

Hi, There. Thank you for being here. My name is Lani harfisani, I am the owner of BogdiSupplier. It is such an honor for me to welcome you here.

Recent Post

The post Salmonella-Laced Kratom Worth $400K Seized By CBP In Detroit From China appeared first on Bogdi Supplier.

Prevent World Kratom Ban, Don’t Be Silenced

LaniBogdi — Sun, 01 Aug 2021 16:49:31 +0000

Monday, 08/01/2021

By American Kratom Association

Prevent World Kratom Ban, Don't Be Silenced

Prevent World Kratom Ban

Prevent World Kratom Ban, Don't Be Silenced

The American Kratom Association is collecting comments from kratom consumers to submit in response to the FDA.

The FDA is asking the World Health Organization (W.H.O.) & U.N. to consider banning kratom internationally.

SO WE MUST COLLECT AS MANY KRATOM CONSUMER COMMENTS AS POSSIBLE BY AUGUST 9TH 2021! These “formal comments” will be used as proof that kratom shouldn’t be banned.

How you can protect kratom from an international ban?
Please submit your comments, even if you already entered via Federal Registry. The AKA is working hard to prompt as many kratom consumer comments as possible! Your comment, combined with getting others to comment, will make a huge difference.

Why comment if I already added a comment on the Federal Registry site?
-THE AKA HAS CONFIRMED THAT THE FDA IS NOT REQUIRED TO SUBMIT ANY COMMENTS TO THE UN EXPERT COMMITTEE — THEY ONLY HAVE TO “CONSIDER” THEM.
Submitting via the form below will ensure both the W.H.O. and the UN expert committee, as well as the FDA, hear your voice.

-- COMMENT NOW --

By American Kratom Association

Nano Machine Result

Hi, There. Thank you for being here. My name is Lani harfisani, I am the owner of BogdiSupplier. It is such an honor for me to welcome you here.

Recent Post

The post Prevent World Kratom Ban, Don’t Be Silenced appeared first on Bogdi Supplier.

Oklahoma Passes KCPA…!

LaniBogdi — Sun, 01 Aug 2021 16:27:55 +0000

Monday, 08/01/2021

Bogdi Kratom Media Team

Oklahoma Passes KCPA!

Oklahoma Map

Oklahoma Passes KCPA!

We’re very excited to announce that Oklahoma is the latest state to pass the Kratom Consumer Protection Act. The Governor of Oklahoma has approved HB 1784, the Kratom Consumer Protection Act in May 2021.

Oklahoma is the 5th state to pass the KCPA. Congratulations to the Oklahoma kratom team!

Nano Machine Result

Hi, There. Thank you for being here. My name is Lani harfisani, I am the owner of BogdiSupplier. It is such an honor for me to welcome you here.

Recent Post

The post Oklahoma Passes KCPA…! appeared first on Bogdi Supplier.

Myriad Benefits of Kratom Leaves

LaniBogdi — Sat, 17 Jul 2021 13:03:05 +0000

Saturday, 07/17/2021

Agus C. – Bogdi Kratom Media Team

Myriad Benefits of Kratom Leaves

Kratom Leaf

Contents of Kratom Leaves

The various benefits of kratom leaves cannot be separated from the content in it. Kratom leaves contain at least 40 types of alkaloid compounds, including: Mitragynine 7-hydroxymitragynine, Speciociliatine, Corynantheidine, Speciogynine, Paynantheine, Mitraphylline. Not only the above alkaloid compounds, kratom leaves also contain flavonoid antioxidants, terpenoids, saponins, polyphenols, and glycosides.

Various Benefits of Kratom Leaves

Because it contains various substances above, kratom leaves are considered to provide painkillers, anxiety, and sleep disorders, stimulant effect or generate energy, become more alert and increase feelings of happiness, analgesic, anti-inflammatory or muscle relaxant effects, symptoms of fibromyalgia or intolerance to stress and pain.

Kratom plants are also known as purik or ketum leaves. Having the Latin name Mitragynaspeciosa (from the Rubiaceae family) kratom or kratom leaves has been widely used in West Kalimantan. This leaf is commonly used as an herbal painkiller.

Kratom leaf is a plant that has long been known as a herbal medicine. Kratom leaves can use to berelieve pain, anxiety, and sleep disorders.

Kratom or purik leaf (Mitragynaspeciosa) is a tropical plant that grows widely in Southeast Asia, such as Indonesia. This plant has long been used as a traditional medicine by the local community. In Indonesia itself, kratom leaves are often processed into herbs or herbal teas. In addition, kratom is also available in the form of powder or powder and capsules.

To consume it, usually kratom leaves can be eaten raw, brewed like tea, or converted into capsules, tablets, powder, and liquid to be consumed. Chewing kratom leaves is usually done to produce energy such as when consuming caffeine, or as a traditional remedy for ailments, ranging from diarrhea to body aches. Benefits of kratom leaves very good for health.

First, in the use of low doses, kratom can provide a stimulant effect or generate energy, become more alert and increase feelings of happiness. The main active ingredients of kratom are the alkaloids mitraginine and 7-hydroxymitragynine which have been shown to provide analgesic, anti-inflammatory or muscle relaxant effects.

Benefits of kratom leaves also can be useto relieve the symptoms of fibromyalgia or intolerance to stress and pain which is usually characterized by body aches, difficulty sleeping and fatigue. The popularity of kratom leaves had attracted attention some time ago.

Having high economic value, kratom leaves, which are also known as purik leaves, have become excellent for economic purposes. The popularity of kratom leaves or purik leaves soared because of the high selling price. Many people start to plant and trade kratom leaves because of their favorable economic value.

Kratom (MitragynaspeciosaKorth) is a tropical plant originating from Southeast Asia (Muang Thailand, Indonesia, Malaysia, Myanmar, Philippines) and Papua New Guinea. We can easily find Kratom in the community and trade it online. Currently, the use of kratom is very widespread in the community. The benefits of kratom leaves in the community is usually used by chewing a few pieces of kratom leaves every day.

There are also those who use kratom leaves by making them into powder or even brewed as herbal teas. In routine use, the average community can use 10-60 kratom leaves or more every day to treat the disease. Kratom contains more than 40 types of alkaloids including mitraginin, 7-hydroxymitraginine, several types of flavonoids, terpenoids, saponins and several types of glycosides.

The active compounds mitraginin and 7-hydroxymitraginine in kratom make kratom have a strong analgesic effect potential. 7-hydroxylmitraginine has an analgesic effect 13 times higher than morphine in relieving pain. Mitraginine, specioginine, painantein, and speciolitin work by binding to opioid receptors in the brain causing a mood-elevating effect and a feeling of pleasure. benefits of kratom leaves make this herb more famous.

These ingredients are what causeskratom to be widely used in the community as a pain reliever, overcoming fatigue and increasing morale. The effect of kratom on humans actually also depends on the dose of kratom taken in one drink. At low doses, kratom has a stimulatory effect on improving mood.

Derived from a tree native to Southeast Asia, kratom can be taken as a pill, capsule, or extract, or it can even be brewed as a tea. The benefits of kratom leavesalso give substance acts on the opioid receptors in the brain. If you use it in low doses, kratom is a stimulant. While in higher doses it can relieve pain. Some people claim to use kratom as a substitute for opioids in an effort to limit their use of opioids and stop their addiction to opioids. Others use kratom recreationally for personal relaxation or to treat pain, anxiety, or depression.

Nano Machine Result

Hi, There. Thank you for being here. My name is Lani harfisani, I am the owner of BogdiSupplier. It is such an honor for me to welcome you here.

Recent Post

The post Myriad Benefits of Kratom Leaves appeared first on Bogdi Supplier.